心臓代謝リスク因子管理のためのスマートフォンアプリベースの介入:体系的なレビューとメタ解析
Makiko Abe1, Tetsuo Hirata2, Natsumi Morito2,3
1Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. mabe@fukuoka-u.ac.jp.
まとめ
スマートフォンのアプリは 血糖,BMI,LDLコレステロールなどの 心臓代謝の危険因子を 大幅に軽減します これらの健康効果は12ヶ月減るので 継続的な介入の必要性を強調しています
科学分野:
- 心血管の健康
- 代謝 健康
- デジタルヘルスの介入
背景:
- 以前の研究では スマートフォンのアプリによる介入が 血圧に与える影響を明らかにしました
- この研究は,より広範な心代謝リスク因子への影響を分析することによって,以前の研究を拡張しています.
研究 の 目的:
- スマートフォンアプリによる介入が 心臓代謝の危険因子に及ぼす影響を二次的に分析する.
- 断食時の血糖値,BMI,腰周,体重,脂質プロフィールの変化を評価する.
主な方法:
- MEDLINE,コクラン・ライブラリ,イクシの系統的な検索で,関連するランダム化制御試験と観察試験を検索する.
- ランダム効果モデルを使用して,平均変化と95%信頼区間 (CI) をまとめました.
- 46,459人の参加者を含む76件の研究で,アプリベースの介入と通常のケアを比較した.
主要な成果:
- 6ヶ月後には,空腹の血糖,BMI,腰周,体重,LDLコレステロール,総コレステロール,トリグリセリドの有意な減少が観察されました.
- これらのマーカーの効果は12ヶ月減少し,BMIの減少は追跡期間と相互作用を示した.
- 血圧の低下はベースライン値に比べて有意な差異はありませんが,東アジア人ではLDLコレステロールの減少が顕著でした.
結論:
- スマートフォンのアプリによる介入は心臓代謝の健康を改善し,自己管理を支援する可能性を示しています.
- 持続的な介入効果は12ヶ月ごとに徐々に減少するので,必要かもしれません.
- LDLコレステロールの減少における民族的差異によって示唆されるように,介入の有効性は異なる集団によって異なる可能性があります.
関連する概念動画
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:15Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:28Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
37
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
37